Oxford Finance LLC
Venture debtAlexandria · Seed–Late Stage · 45 people tracked
Investment thesis
Oxford Finance's real estate team focuses on facility-based healthcare lending across acute, post-acute, and specialty segments in the United States. It offers financing for working capital, acquisitions, refinancing, cash-out recaps, and property transitions, serving both operators and investor-owners of single assets or portfolios. Products include working capital revolvers, senior term loans, Term Loan B and second lien, mezzanine loans, and equity or structured equity, backed by full capital markets capability. Loan sizes range from $5MM to $125MM with tenors up to five years, initial interest-only periods, and amortization up to 25 years.
Source: firm website, verified Aug 25, 2026.
Team · 45 people
from the firm's website & public directories
What they invest in
from 4 of 4 portfolio companiesBiotech ×3Healthtech ×2Medical Devices ×1
HQs:United States×4
Investments · 4 tracked
founders shown can be your intro pathInhibrx develops protein therapeutics, using target biology and protein engineering to create therapeutic candidates in clinical trials for conditions including sarcoma and head and neck cancer.
BiotechLa Jolla, US
Mark Lappe(Executive Officer, Director)inBrendan Eckelman(Director)inDoug Forsyth(Director)Jon Faiz Kayyem(Director)Margery Fischbein(Director)
BoardJudith Li(Director)
Co-investorsLAVLilly Asia VenturesRA Capital
HealthtechNewark, US
John Hendrick(Executive Officer, Director)Tim Dumke(Executive Officer)
BoardStephen Martin(Director)William Link(Director)Ryan Schwarz(Director)Steven Waite(Director)
Co-investorsSV Health InvestorsMPM BioImpactSV Life SciencesVersant Ventures
BiotechBridgewater, US
Navneet Puri(Executive Officer)
Co-investorsH.I.G. CapitalH.I.G. HealthBridge Partners
A biopharmaceutical company that discovers, develops, and delivers medicines and vaccines, with research and development across respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.
BiotechHealthtechMedical DevicesSan Francisco, US
Co-investorsCapital Midwest FundFrazier Life SciencesLongitude CapitalRA CapitalVivo Capital
Portfolio news
latest coverage across their companiesInhibrx · ng.investing.com · Aug 21, 2026
Frequently asked questions
- What stage does Oxford Finance LLC invest at?
- Oxford Finance LLC invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Oxford Finance LLC's typical check size?
- Oxford Finance LLC typically writes checks of $5M – $125M.
- What sectors does Oxford Finance LLC focus on?
- Oxford Finance LLC focuses on Biotech, Healthtech, Medical Devices, PropTech.
- Where is Oxford Finance LLC located?
- Oxford Finance LLC is headquartered in Alexandria, US.
Similar investors
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.
The Alibaba Entrepreneurs Fund is a not-for-profit initiative of Alibaba Group that provides investment capital and strategic guidance to entrepreneurs and young people, focusing on Hong Kong and Taiwan-nexus startups.
OneVentures is a later-stage venture capital firm that backs technology and healthcare companies, providing growth equity and credit alongside strategic and operational support.
OCV Partners is a Los Angeles based venture capital firm backing companies with differentiated technologies in compelling markets, led by former founders leveraging company-building experience.